Combination of Laser Therapy and Phytotherapy for the Treatment of Menopausal Symptoms

The use of standardized extracts of Angelica keiskei and Panax ginseng as a strategy to potentiate the biological effects induced by red laser on postmenopausal symptoms

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

REBEC

Registry ID

RBR-10vj22fr

Enrollment

Unknown

Registered

2025-06-18

Start date

2024-05-05

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause and female climacteric status

Interventions

This randomized, double-blind, comorbidity-stratified clinical trial will investigate the efficacy of red laser, the combination of Angelica keiskei and Panax ginseng (Angelica keiskei e Panax ginseng

E02.594.540

Eligibility

Sex/Gender

Female

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women between 40 and 65 years of age; experiencing amenorrhea for at least 12 months due to natural causes or due to health treatment; characterizing the post-menopausal period

Exclusion criteria

Exclusion criteria: Participants who do not sign the informed consent form; women who have received hormone therapy in the last 6 months; with untreated hypothyroidism; any type of cancer; photosensitivity; cardiac arrhythmias; pacemaker wearers; presence of neurological; renal; hepatic diseases or infectious disease

Design outcomes

Primary

Measure	Time frame
Espera-se encontrar diminuição na pontuação na escala de avaliação da menopausa e dos biomarcadores inflamatórios	—

Secondary

Measure	Time frame
It has no secondary outcome.	—

Countries

Brazil

Contacts

Public ContactRita Alcântara

Universidade Federal de São Carlos- UFSCar

rita.cotta@estudante.ufscar.br+55(16)3351 - 8327.

Outcome results

None listed

Source: REBEC (via WHO ICTRP)